Apollomics, Inc.
APLM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | -0.02 | -0.68 |
| FCF Yield | -318.46% | -60.19% | -4.80% | -5.03% |
| EV / EBITDA | -0.01 | -0.83 | -19.77 | -22.76 |
| Quality | ||||
| ROIC | -713.75% | -116.85% | -69.64% | -45.19% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 0.53 | 0.25 | 0.18 | 0.46 |
| Growth | ||||
| Revenue 3-Year CAGR | -15.05% | 643.20% | -43.99% | – |
| Free Cash Flow Growth | 33.43% | -0.06% | 0.39% | -21.04% |
| Safety | ||||
| Net Debt / EBITDA | 0.21 | 0.51 | 0.72 | -5.56 |
| Interest Coverage | -235.40 | -360.09 | -484.74 | -612.73 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 234.12 | 207.17 | 618.13 | 92,345.00 |